AG
SUPN icon

Algert Global’s Supernus Pharmaceuticals SUPN Stock Holding History

Algert Global’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.24M Buy
+91,070
New +$4.37M 0.05% 602
2026
Q1 		– Sell
-9,510
Closed -$473K – 1328
2025
Q4 		$473K Sell
9,510
-18,820
-66% -$915K 0.01% 956
2025
Q3 		$1.35M Buy
+28,330
New +$1.14M 0.02% 783
2022
Q4 		– Sell
-12,920
Closed -$437K – 1280
2022
Q3 		$437K Buy
12,920
+4,312
+50% +$140K 0.03% 844
2022
Q2 		$249K Buy
8,608
+1,830
+27% +$52.4K 0.02% 966
2022
Q1 		$219K Buy
+6,778
New +$208K 0.01% 1031
2021
Q4 		– Sell
-7,955
Closed -$212K – 1110
2021
Q3 		$212K Buy
+7,955
New +$214K 0.03% 889
2020
Q1 		– Sell
-19,090
Closed -$453K – 513
2019
Q4 		$453K Sell
19,090
-24,033
-56% -$584K 0.14% 215
2019
Q3 		$1.19M Buy
43,123
+20,913
+94% +$620K 0.44% 80
2019
Q2 		$735K Buy
22,210
+3,452
+18% +$118K 0.27% 124
2019
Q1 		$657K Sell
18,758
-6,605
-26% -$246K 0.38% 99
2018
Q4 		$843K Buy
25,363
+17,302
+215% +$744K 0.24% 148
2018
Q3 		$406K Hold
8,061
– – 0.09% 270
2018
Q2 		$482K Sell
8,061
-103,122
-93% -$5.34M 0.1% 249
2018
Q1 		$5.09M Buy
111,183
+44,320
+66% +$1.85M 0.99% 4
2017
Q4 		$2.66M Buy
66,863
+4,182
+7% +$165K 0.63% 49
2017
Q3 		$2.51M Buy
62,681
+10,914
+21% +$472K 0.57% 63
2017
Q2 		$2.23M Sell
51,767
-6,845
-12% -$244K 0.63% 46
2017
Q1 		$1.83M Buy
+58,612
New +$1.57M 0.5% 72

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Algert Global's SUPN Position: Q2 2026 in Review

Algert Global opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 91,070 shares worth $4.24M. The stake represents 0.05% of the portfolio and ranks #602 among its holdings. This is a return to the name: Algert Global previously reported a position in SUPN as recently as Q4 2025.

Algert Global first reported a position in SUPN in Q1 2017 and has held it in 19 quarters since. The position peaked at $5.09M in Q1 2018. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Algert Global held 91,070 shares of Supernus Pharmaceuticals worth $4.24M as of Q2 2026.
  • Supernus Pharmaceuticals was a new Algert Global position in Q2 2026.
  • Supernus Pharmaceuticals made up 0.05% of Algert Global's portfolio in Q2 2026, its #602 holding.
  • Algert Global first reported a position in Supernus Pharmaceuticals in Q1 2017 and has held it in 19 quarters since.
  • Algert Global's Supernus Pharmaceuticals position peaked at $5.09M in Q1 2018.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.